菌群代谢物介导滋养细胞代谢重编程 参与子痫前期
Gut Microbiota Metabolites Mediate Trophoblast Metabolic Reprogramming in Preeclampsia
DOI: 10.12677/acm.2026.1652121, PDF,    科研立项经费支持
作者: 李银娇, 何东岚, 周 俊*:暨南大学第二临床医学院,深圳市人民医院妇科,广东 深圳
关键词: 肠道菌群代谢物代谢重编程胎盘滋养细胞子痫前期Gut Microbiota Metabolites Metabolic Reprogramming Placental Trophoblasts Preeclampsia
摘要: 子痫前期是妊娠期高发且严重威胁母婴安全的并发症,胎盘滋养细胞功能异常与代谢紊乱是其核心病理环节。近年来,肠道菌群及其代谢产物在妊娠相关疾病中的调控作用成为研究热点,肠–胎盘轴机制为阐释子痫前期发病机理提供了全新视角。肠道菌群失调可引发短链脂肪酸、胆汁酸、色氨酸代谢物及三甲胺-N-氧化物等代谢物谱异常,通过能量代谢调控、表观遗传修饰、免疫微环境重塑等通路,诱导胎盘滋养细胞发生代谢重编程,抑制滋养细胞侵袭与螺旋动脉重塑,加剧胎盘氧化应激与炎症反应,最终推动子痫前期发生发展。本文系统梳理肠道菌群代谢物的种类与功能、滋养细胞代谢异常特征,阐明菌群代谢物介导滋养细胞代谢重编程的分子通路,总结临床生物标志物开发与微生态干预的研究进展,展望精准防治策略,为子痫前期的早期预警与靶向治疗提供理论依据与新思路。
Abstract: Preeclampsia is a highly prevalent and life-threatening complication of pregnancy, with placental trophoblast dysfunction and metabolic disorders serving as its core pathological link. In recent years, the regulatory role of the gut microbiota and its metabolites in pregnancy-related diseases has become a research hotspot, and the “gut-placenta axis” mechanism provides a novel perspective for elucidating the pathogenesis of preeclampsia. Gut microbiota dysbiosis leads to abnormal profiles of metabolites such as short-chain fatty acids (SCFAs), bile acids, tryptophan metabolites, and trimethylamine-N-oxide (TMAO). These metabolites induce metabolic reprogramming in placental trophoblasts through pathways including energy metabolism regulation, epigenetic modification, and immune microenvironment remodeling. Such reprogramming inhibits trophoblast invasion and spiral artery remodeling, exacerbates placental oxidative stress and inflammatory responses, and ultimately promotes the development of preeclampsia. This paper systematically reviews the types and functions of gut microbiota metabolites, the characteristics of trophoblast metabolic abnormalities, clarifies the molecular pathways of microbiota metabolites mediating trophoblast metabolic reprogramming, summarizes research advances in clinical biomarker development and microecological interventions, and prospects precise prevention and treatment strategies. It provides theoretical basis and new ideas for early warning and targeted therapy of preeclampsia.
文章引用:李银娇, 何东岚, 周俊. 菌群代谢物介导滋养细胞代谢重编程 参与子痫前期[J]. 临床医学进展, 2026, 16(5): 3063-3069. https://doi.org/10.12677/acm.2026.1652121

参考文献

[1] Kassebaum, N.J., Lopez, A.D., Murray, C.J.L. and Lozano, R. (2014) A Comparison of Maternal Mortality Estimates from GBD 2013 and Who. The Lancet, 384, 2209-2210. [Google Scholar] [CrossRef] [PubMed]
[2] Melchiorre, K., Giorgione, V. and Thilaganathan, B. (2022) The Placenta and Preeclampsia: Villain or Victim? American Journal of Obstetrics and Gynecology, 226, S954-S962. [Google Scholar] [CrossRef] [PubMed]
[3] Ma, N., Cao, H., Ma, Y., Yin, J., Yan, J., Pei, J., et al. (2025) The Gut-Placenta Axis in Preeclampsia: Unraveling the Regulatory Network and Clinical Prospects in Pathogenesis. Frontiers in Cellular and Infection Microbiology, 15, Article ID: 1697739. [Google Scholar] [CrossRef
[4] Jin, J., Gao, L., Zou, X., Zhang, Y., Zheng, Z., Zhang, X., et al. (2022) Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts. Circulation Research, 131, 492-506. [Google Scholar] [CrossRef] [PubMed]
[5] Wang, J., Gao, Y., Ren, S., Li, J., Chen, S., Feng, J., et al. (2024) Gut Microbiota-Derived Trimethylamine N-Oxide: A Novel Target for the Treatment of Preeclampsia. Gut Microbes, 16, Article 2311888. [Google Scholar] [CrossRef] [PubMed]
[6] Mackay, C.R. and Marques, F.Z. (2022) Dysbiosis in Preeclampsia and Treatment with Short Chain Fatty Acids. Circulation Research, 131, 507-509. [Google Scholar] [CrossRef] [PubMed]
[7] Gomez-Arango, L.F., Barrett, H.L., McIntyre, H.D., Callaway, L.K., Morrison, M. and Dekker Nitert, M. (2016) Increased Systolic and Diastolic Blood Pressure Is Associated with Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy. Hypertension, 68, 974-981. [Google Scholar] [CrossRef] [PubMed]
[8] Chang, Y., Chen, Y., Zhou, Q., Wang, C., Chen, L., Di, W., et al. (2020) Short-Chain Fatty Acids Accompanying Changes in the Gut Microbiome Contribute to the Development of Hypertension in Patients with Preeclampsia. Clinical Science, 134, 289-302. [Google Scholar] [CrossRef] [PubMed]
[9] Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., et al. (2025) Trimethylamine-n-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites, 15, Article 220. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, L., Cai, M., Li, L., Zhang, X., Xu, Y., Xiao, J., et al. (2021) Gut Microbiota Changes in Preeclampsia, Abnormal Placental Growth and Healthy Pregnant Women. BMC Microbiology, 21, Article No. 256. [Google Scholar] [CrossRef] [PubMed]
[11] Li, G., Niu, H., Xie, M., Yang, M., Li, M., Hao, Y., et al. (2025) Study on Characteristics of Gut Flora Composition of Pregnant Women with Preeclampsia. BMC Pregnancy and Childbirth, 25, Article No. 636. [Google Scholar] [CrossRef] [PubMed]
[12] Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, X., Zeng, X., Li, X., Xin, S., Zhang, F., Liu, F., et al. (2024) Landscapes of Gut Bacterial and Fecal Metabolic Signatures and Their Relationship in Severe Preeclampsia. Journal of Translational Medicine, 22, Article No. 360. [Google Scholar] [CrossRef] [PubMed]
[14] Tang, R., Xiao, G., Jian, Y., Yuan, Q., Jiang, C. and Wang, W. (2022) The Gut Microbiota Dysbiosis in Preeclampsia Contributed to Trophoblast Cell Proliferation, Invasion, and Migration via LncRNA Bc030099/NF-κB Pathway. Mediators of Inflammation, 2022, Article ID: 6367264. [Google Scholar] [CrossRef] [PubMed]
[15] Alhasan, M.M., Landa, M.S., García, S.I., Gerlach, R.G., Harb, H., Fahlbusch, F.B., et al. (2024) Distinct Gut Microbial Signature and Altered Short Chain Fatty Acid Metabolism at Disease Onset in a Rat Preclinical Model of Superimposed Preeclampsia. Scientific Reports, 14, Article No. 32137. [Google Scholar] [CrossRef] [PubMed]
[16] den Besten, G., van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D. and Bakker, B.M. (2013) The Role of Short-Chain Fatty Acids in the Interplay between Diet, Gut Microbiota, and Host Energy Metabolism. Journal of Lipid Research, 54, 2325-2340. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, Q., Qian, Y., Feng, M., Zhang, H. and Xie, H. (2025) Integrating Urine Metabolomic Biomarkers and Machine Learning Algorithms to Predict Preeclampsia. European Journal of Medical Research, 30, Article No. 1103. [Google Scholar] [CrossRef
[18] Shukla, V. and Soares, M.J. (2022) Modeling Trophoblast Cell-Guided Uterine Spiral Artery Transformation in the Rat. International Journal of Molecular Sciences, 23, Article 2947. [Google Scholar] [CrossRef] [PubMed]
[19] Ali, M., Ahmed, M., Memon, M., Chandio, F., Shaikh, Q., Parveen, A., et al. (2024) Preeclampsia: A Comprehensive Review. Clinica Chimica Acta, 563, Article 119922. [Google Scholar] [CrossRef] [PubMed]
[20] Lee, P., Gudino, P., Umana, C.D., Tufail, M.U., Gallippi, V. and Jim, B. (2025) Updates on Preeclampsia: Pathogenesis, Biomarkers, Diagnosis, and Management. Cardiology in Review. [Google Scholar] [CrossRef] [PubMed]
[21] Grismaldo R, A., Luévano‐Martínez, L.A., Reyes, M., García‐Márquez, G., García‐Rivas, G. and Sobrevia, L. (2024) Placental Mitochondrial Impairment and Its Association with Maternal Metabolic Dysfunction. The Journal of Physiology. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, Z., Wang, C., Pei, J., Li, M. and Gu, W. (2022) SIRT1: A Novel Protective Molecule in Pre-Eclampsia. International Journal of Medical Sciences, 19, 993-1002. [Google Scholar] [CrossRef] [PubMed]
[23] Li, B., Shi, Y., Qiu, W., Lin, Q., Zeng, S., Hou, Y., et al. (2023) Limosilactobacillus Reuteri Ameliorates Preeclampsia in Mice via Improving Gut Dysbiosis and Endothelial Dysfunction. Biomedicine & Pharmacotherapy, 161, Article 114429. [Google Scholar] [CrossRef] [PubMed]
[24] McDougall, A., Nguyen, R., Nguyen, P., Allen, C., Cheang, S., Makama, M., et al. (2024) The Effects of Probiotics Administration during Pregnancy on Preeclampsia and Associated Maternal, Fetal, and Newborn Outcomes: A Systematic Review and Meta-Analysis. American Journal of Obstetrics & Gynecology MFM, 6, Article 101322. [Google Scholar] [CrossRef] [PubMed]
[25] 吴飘, 张殿朋, 韩雅杰, 等. 天然活性成分靶向肠道菌群调控脂质代谢分子机制研究进展[J/OL]. 微生物学报: 1-19. 2026-05-25.[CrossRef
[26] Ruiz-Triviño, J., Álvarez, D., Cadavid J., Á.P. and Alvarez, A.M. (2023) From Gut to Placenta: Understanding How the Maternal Microbiome Models Life-Long Conditions. Frontiers in Endocrinology, 14, Article ID: 1304727. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, F., Tian, J., Li, J., Zhang, T. and Wang, X. (2025) Akkermansia Muciniphila Alleviates Metabolic Disorders through Gut Microbiota-Mediated Tryptophan Regulation. AMB Express, 15, Article No. 181. [Google Scholar] [CrossRef
[28] Zambella, E., Peruffo, B., Guarano, A., Inversetti, A. and Di Simone, N. (2024) The Hidden Relationship between Intestinal Microbiota and Immunological Modifications in Preeclampsia Pathogenesis. International Journal of Molecular Sciences, 25, Article 10099. [Google Scholar] [CrossRef] [PubMed]
[29] Kanannejad, Z., Taylor, W.R., Ghatee, M.A. and Mohkam, M. (2026) Microbial Regulation of Immune Tolerance during Embryonic Implantation and Pregnancy. Journal of Reproductive Immunology, 175, Article 104898. [Google Scholar] [CrossRef
[30] Yousefi, F., Salehi, B., Ghorbani, N., Yaghmayee, S. and Eslami, M. (2026) Integrative Analysis of Placental Metabolic Reprogramming and Microbiome Alterations in Gestational Diabetes Mellitus (GDM). Acta Diabetologica. [Google Scholar] [CrossRef
[31] Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., et al. (2017) Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity. American Journal of Obstetrics and Gynecology, 217, 282-302. [Google Scholar] [CrossRef] [PubMed]
[32] Kalapouti, E., Bothou, A., Harizopoulou, V., Vlachou, M., Vasiliki Zampeli, M. and Diamanti, A. (2025) Lipidomic Signatures in Maternal Blood and Placenta: Systematic Evidence Linking Lipid Profiles to Pregnancy Outcomes and Fetal Growth. Metabolism Open, 28, Article 100398. [Google Scholar] [CrossRef
[33] Chakaroun, R.M., Olsson, L.M. and Bäckhed, F. (2022) The Potential of Tailoring the Gut Microbiome to Prevent and Treat Cardiometabolic Disease. Nature Reviews Cardiology, 20, 217-235. [Google Scholar] [CrossRef] [PubMed]